Hypoglycemia in a diabetic patient during hepatitis C therapy

Hepatology

Volumn 63, Issue 6, 2016, Pages 2065-2066

  Soriano, Vicente ^a   Barreiro, Pablo ^a   de Mendoza, Carmen ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEDIPASVIR PLUS SOFOSBUVIR; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; CASE REPORT; CHRONIC HEPATITIS C; DIABETIC PATIENT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HEPATITIS C VIRUS GENOTYPE 1; HUMAN; HYPOGLYCEMIA; INSULIN SENSITIVITY; LETTER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84978204251     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28137     Document Type: Letter

References (4)

1. Simon T, Chung R. The new hepatitis C virus bottleneck: can delaying therapy be justified? Hepatology 2015;62:1004-1012.
2. Cacoub P, Gragnani L, Comarmond C, Zignego A. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis 2014;46(Suppl 5):S165-S173.
3. Serfaty L, Capeau J. Hepatitis C insulin resistance and diabetes: clinical and pathogenic data. Liver Int 2009;29(Suppl 2):13-25.
4. Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 2009;49:739-744.